Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,867 | -4,671 | -12,541 | -4,240 | -9,295 |
| Depreciation Amortization | 91 | 47 | 97 | 48 | 69 |
| Accounts receivable | N/A | -1,070 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -1,673 | N/A | N/A | N/A |
| Other Working Capital | -397 | -1,309 | 3,770 | 1,057 | -4,302 |
| Other Operating Activity | 758 | 3,231 | 407 | 206 | 40 |
| Operating Cash Flow | $-7,416 | $-5,444 | $-8,267 | $-2,929 | $-13,488 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | -4 | -4 | -5 |
| Other Investing Activity | -4,857 | 0 | 0 | 0 | -20 |
| Investing Cash Flow | $-4,857 | $N/A | $-4 | $-4 | $-25 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 260 | N/A | N/A | N/A |
| Other Financing Activity | 25,690 | -65 | 6,044 | 684 | 84 |
| Financing Cash Flow | $25,690 | $194 | $6,044 | $684 | $84 |
| Exchange Rate Effect | -129 | -27 | 171 | -2 | 616 |
| Beginning Cash Position | 8,185 | 8,230 | 10,344 | 10,278 | 23,432 |
| End Cash Position | 21,474 | 2,954 | 8,289 | 8,028 | 10,619 |
| Net Cash Flow | $13,289 | $-5,276 | $-2,056 | $-2,250 | $-12,813 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,416 | -5,444 | -8,267 | -2,929 | -13,488 |
| Free Cash Flow | -7,416 | -5,444 | -8,267 | -2,929 | -13,488 |